A detailed history of Fmr LLC transactions in Xencor Inc stock. As of the latest transaction made, Fmr LLC holds 4,035 shares of XNCR stock, worth $95,306. This represents 0.0% of its overall portfolio holdings.

Number of Shares
4,035
Previous 3,735 8.03%
Holding current value
$95,306
Previous $82,000 7.32%
% of portfolio
0.0%
Previous 0.0%

Shares

13 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 13, 2024

BUY
$18.21 - $24.5 $5,463 - $7,350
300 Added 8.03%
4,035 $76,000
Q1 2024

May 13, 2024

SELL
$18.65 - $26.52 $47.7 Million - $67.9 Million
-2,559,170 Reduced 99.85%
3,735 $82,000
Q4 2023

Feb 13, 2024

SELL
$16.53 - $21.42 $14.4 Million - $18.6 Million
-868,990 Reduced 25.32%
2,562,905 $54.4 Million
Q3 2023

Nov 13, 2023

SELL
$20.08 - $25.39 $3.9 Million - $4.93 Million
-194,332 Reduced 5.36%
3,431,895 $69.2 Million
Q2 2023

Aug 11, 2023

SELL
$24.77 - $29.9 $3.15 Million - $3.8 Million
-127,139 Reduced 3.39%
3,626,227 $90.5 Million
Q1 2023

May 11, 2023

SELL
$25.95 - $36.95 $1.87 Million - $2.66 Million
-71,987 Reduced 1.88%
3,753,366 $105 Million
Q4 2022

Feb 13, 2023

SELL
$24.79 - $30.86 $35.2 Million - $43.8 Million
-1,418,847 Reduced 27.06%
3,825,353 $99.6 Million
Q3 2022

Nov 10, 2022

SELL
$24.62 - $32.44 $3.49 Million - $4.6 Million
-141,811 Reduced 2.63%
5,244,200 $136 Million
Q2 2022

Aug 12, 2022

SELL
$19.74 - $29.01 $9.5 Million - $14 Million
-481,462 Reduced 8.21%
5,386,011 $147 Million
Q1 2022

May 13, 2022

SELL
$26.68 - $41.63 $50.5 Million - $78.9 Million
-1,894,105 Reduced 24.4%
5,867,473 $157 Million
Q4 2021

Feb 14, 2022

SELL
$33.67 - $43.44 $19.7 Million - $25.4 Million
-584,858 Reduced 7.01%
7,761,578 $311 Million
Q3 2021

Nov 15, 2021

BUY
$30.65 - $35.68 $2.48 Million - $2.89 Million
80,872 Added 0.98%
8,346,436 $273 Million
Q2 2021

Aug 13, 2021

BUY
$34.33 - $44.68 $284 Million - $369 Million
8,265,564 New
8,265,564 $285 Million

Others Institutions Holding XNCR

About Xencor Inc


  • Ticker XNCR
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 59,698,100
  • Market Cap $1.41B
  • Description
  • Xencor, Inc., a clinical stage biopharmaceutical company, focuses on the discovery and development of engineered monoclonal antibody and cytokine therapeutics to treat patients with cancer and autoimmune diseases. The company provides Sotrovimab that targets the SARS-CoV-2 virus; Ultomiris for the treatment of patients with paroxysmal nocturnal ...
More about XNCR
Track This Portfolio

Track Fmr LLC Portfolio

Follow Fmr LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Fmr LLC, based on Form 13F filings with the SEC.

News

Stay updated on Fmr LLC with notifications on news.